Big Move For Chembio Diagnostics, Inc.
Mon, Apr 05, 2021 at 05:30 PM
Chembio Diagnostics, Inc. (CEMI:NASDAQ) soared at $5.64, a gain of 60.2%. The stock appeared on our News Catalysts scanner on Mon, Apr 05, 2021 at 04:14 PM in the 'MISCELLANEOUS' category. From Thu, Mar 18, 2021, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Jan 26, 2021 at $8.75 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Chembio Diagnostics, Inc. (CEMI:NASDAQ)
Chembio Diagnostics Inc develops, manufacture markets & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.
Top 10 Gainers:
- Chembio Diagnostics, Inc. (CEMI:NASDAQ), 60.23%
- Xcel Brands, Inc. (XELB:NASDAQ), 51.27%
- DMYD (DMYD:NYSE), 40.76%
- Sequential Brands Group, Inc. (SQBG:NASDAQ), 32.4%
- VVOS (VVOS:NASDAQ), 27.21%
- Moxian, Inc. (MOXC:NASDAQ), 26.16%
- U.S. Global Investors, Inc. (GROW:NASDAQ), 25.14%
- Performant Financial Corporation (PFMT:NASDAQ), 25%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 24.53%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 24.18%